← Back to Search

Room Setting Preferences for Cancer Care

N/A

Waitlist Available

Led By MarieBerta Vidal

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient must be able to read and speak English or Spanish

Patient must have advanced cancer, defined as locally advanced, metastatic, or incurable disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 days after visit

Awards & highlights

Study Summary

This trial looks at patients' and caregivers' preferences for room setting and waiting time in an outpatient cancer supportive/palliative care center.

Who is the study for?

This trial is for patients with advanced cancer and their caregivers. Participants must be first-time visitors to the UTMDACC outpatient Supportive Care Center, able to give informed consent, and read/speak English or Spanish. Patients with delirium, dementia, or without a caregiver are excluded.Check my eligibility

What is being tested?

The study aims to understand preferences regarding room settings and waiting times at an outpatient supportive/palliative care center by using questionnaires administered to both patients with advanced cancer and their caregivers.See study design

What are the potential side effects?

Since this trial involves questionnaire administration rather than medical interventions, there are no direct physical side effects associated with participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can read and speak English or Spanish.

Select...

My cancer is advanced and cannot be cured with surgery or radiation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 days after visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 days after visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 days after visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Preference of exam room over waiting room as soon as checking in until the nurse is ready for a patient assessed using questionnaire

Side effects data

From 2020 Phase 3 trial • 177 Patients • NCT01817075

13%

Rash maculo-papular

10%

Skin and subcutaneous tissue disorders - Other, specify

Mucositis oral

Sepsis

Skin ulceration

Urticaria

100%

80%

60%

40%

20%

Study treatment Arm

Arm I (CHG Cleansing Wipe)

Arm II (Control)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (questionnaire)Experimental Treatment1 Intervention

Patients and their caregivers complete a questionnaire over 15 minutes either in person or over the phone within 3 days after their supportive care center visit.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,967 Previous Clinical Trials

1,804,396 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,261 Total Patients Enrolled

MarieBerta VidalPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Questionnaire Administration Clinical Trial Eligibility Overview. Trial Name: NCT03671226 — N/A

Cancer Research Study Groups: Supportive Care (questionnaire)

Cancer Clinical Trial 2023: Questionnaire Administration Highlights & Side Effects. Trial Name: NCT03671226 — N/A

Questionnaire Administration 2023 Treatment Timeline for Medical Study. Trial Name: NCT03671226 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still spots available in the trial for volunteers?

"Per clinicaltrials.gov, this trial is no longer actively looking for participants. Initially posted on September 28th 2018 and last modified October 20th 2022, the study has ceased recruitment; fortunately, there are 2,422 other trials currently accepting enrolment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center

2018. "Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03671226.